Australia markets open in 8 hours 43 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
36.25+1.63 (+4.71%)
As of 10:17AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts15151616
Avg. Estimate-0.64-0.68-2.83-3.12
Low estimate-0.88-0.95-3.65-3.72
High estimate-0.41-0.48-2.18-2.42
Year ago EPS-0.35-0.55-2.06-2.83
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts13131414
Avg. Estimate610k610k5.31M13.1M
Low estimateN/AN/AN/AN/A
High estimate4M4M23M115M
Year ago sales8.77M536k9.43M5.31M
Sales growth (year/est)-93.00%13.80%-43.70%146.70%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.41-0.48-0.52-0.58
Actual EPS-0.35-0.55-0.57-0.57
Difference0.06-0.07-0.050.01
Surprise %14.60%-14.60%-9.60%1.70%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.64-0.68-2.83-3.12
7 days ago-0.64-0.68-2.83-3.12
30 days ago-0.61-0.65-2.75-2.97
60 days ago-0.61-0.65-2.75-2.97
90 days ago-0.61-0.65-2.75-2.97
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days5564
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXENEIndustrySector(s)S&P 500
Current qtr.-82.90%N/AN/AN/A
Next qtr.-23.60%N/AN/AN/A
Current year-37.40%N/AN/AN/A
Next year-10.20%N/AN/AN/A
Next 5 years (per annum)57.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A